![]() |
Volumn 59, Issue 6, 2003, Pages 471-474
|
Effect of doxercalciferol (1α-hydroxyvitamin D2) on PTH, bone turnover and bone mineral density in a hemodialysis patient with persistent secondary hyperparathyroidism post parathyroidectomy
|
Author keywords
Bone mineral density; Bone turnover; Doxercalciferol; Hemodialysis
|
Indexed keywords
ALKALINE PHOSPHATASE BONE ISOENZYME;
CALCITRIOL;
CALCIUM;
CALCIUM CARBONATE;
COLLAGEN TYPE 1;
DOXERCALCIFEROL;
PARATHYROID HORMONE;
PHOSPHATE BINDING AGENT;
PHOSPHORUS;
VITAMIN D DERIVATIVE;
1 ALPHA HYDROXYERGOCALCIFEROL;
1 ALPHA-HYDROXYERGOCALCIFEROL;
ERGOCALCIFEROL;
ADULT;
ARTICLE;
BACKACHE;
BONE DENSITY;
BONE MINERAL;
BONE TURNOVER;
CASE REPORT;
CHRONIC KIDNEY DISEASE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FEMUR;
HEMODIALYSIS;
HEMODIALYSIS PATIENT;
HUMAN;
HYPERCALCEMIA;
HYPERPHOSPHATEMIA;
LAMINECTOMY;
LUMBAR SPINE;
MALE;
MINERAL METABOLISM;
PARATHYROIDECTOMY;
SECONDARY HYPERPARATHYROIDISM;
SPINAL CORD TUMOR;
TREATMENT OUTCOME;
BONE REMODELING;
METABOLISM;
RENAL REPLACEMENT THERAPY;
ADULT;
BONE DENSITY;
BONE REMODELING;
ERGOCALCIFEROLS;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
MALE;
PARATHYROID HORMONE;
PARATHYROIDECTOMY;
RENAL DIALYSIS;
|
EID: 0038715733
PISSN: 03010430
EISSN: None
Source Type: Journal
DOI: 10.5414/cnp59471 Document Type: Article |
Times cited : (4)
|
References (8)
|